Join to View Full Profile
2901 Blue Ridge RdSte 200Raleigh, NC 27607
Phone+1 919-784-6875
Fax+1 919-784-6890
Dr. Hacker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Gynecologic Oncology, 2015 - 2018
University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 2011 - 2015
University of North Carolina at Chapel Hill School of MedicineClass of 2011
Certifications & Licensure
NC State Medical License 2025 - 2025
NY State Medical License 2018 - 2025
MI State Medical License 2015 - 2019
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 2 citationsA working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining th...Casey M Cosgrove, Dmitriy Zamarin, Jose R Conejo-Garcia, Kari E Hacker, Roberto Vargas
Journal of the National Cancer Institute. 2025-09-01 - HER2 expression in an endometrial cancer cohort.Kari E Hacker, Kathryn A Fleming, Mamta Gupta, Bhavana Pothuri
Gynecologic Oncology. 2025-08-05 - Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-wo...Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, Erinn M Hade, Carson Smitherman
Gynecologic Oncology. 2025-08-01
Press Mentions
What Can We Do About Health Disparities in the Diagnosis and Treatment of Endometrial Cancer?August 27th, 2024- After Clovis Pulls Third-Line Indication, What Is Rucaparib’s Future for Ovarian Cancer?July 27th, 2022
Grant Support
- New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian CarcinomaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
